Bernhard Muellinger

The Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) In Vitro System: Design and Experimental Protocol

C. Lehr, U. Schaefer, Stephanie Hein, 2010, Alternatives to laboratory animals : ATLA.

Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease.

K. Haeussinger, L. Ziegler‐Heitbrock, M. Menzel, 2006, Vaccine.

Inhalative vaccination with pneumococcal polysaccharide in healthy volunteers.

K. Haeussinger, L. Ziegler‐Heitbrock, M. Menzel, 2005, Vaccine.

Physical properties, lung deposition modeling, and bioactivity of recombinant GM-CSF aerosolised with a highly efficient nebulizer.

Fabio Ferrari, B. Trapnell, Takuji Suzuki, 2011, Pulmonary pharmacology & therapeutics.

Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine

Andrew R. Martin, T. Corcoran, B. Rothen‐Rutishauser, 2020, Journal of aerosol medicine and pulmonary drug delivery.

Advances in soft mist inhalers

W. Nijdam, H. Ong, N. Buchmann, 2023, Expert opinion on drug delivery.

Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma

K. Rabe, C. Vogelmeier, P. Kardos, 2014, European Respiratory Journal.

Inhaled sargramostim and whole lung lavage (WLL) as therapy of autoimmune pulmonary alveolar proteinosis (aPAP)

C. Tinelli, M. Zorzetto, B. Trapnell, 2016 .

The use of combined single photon emission computed tomography and X-ray computed tomography to assess the fate of inhaled aerosol.

Gabriela Apiou-Sbirlea, Diane Perchet, Joy Conway, 2011, Journal of aerosol medicine and pulmonary drug delivery.